Annual D&A
$30.89 M
-$2.21 M-6.67%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual depreciation & amortization is $30.89 million, with the most recent change of -$2.21 million (-6.67%) on December 31, 2023.
- During the last 3 years, ABCL annual D&A has risen by +$25.62 million (+486.11%).
- ABCL annual D&A is now -6.67% below its all-time high of $33.10 million, reached on December 31, 2022.
Performance
ABCL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$38.30 M
+$258.00 K+0.68%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly depreciation & amortization is $38.30 million, with the most recent change of +$258.00 thousand (+0.68%) on September 30, 2024.
- Over the past year, ABCL quarterly D&A has increased by +$258.00 thousand (+0.68%).
- ABCL quarterly D&A is now at all-time high.
Performance
ABCL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$92.21 M
+$30.89 M+50.37%
September 30, 2024
Summary
- As of February 7, 2025, ABCL TTM depreciation & amortization is $92.21 million, with the most recent change of +$30.89 million (+50.37%) on September 30, 2024.
- Over the past year, ABCL TTM D&A has increased by +$30.89 million (+50.37%).
- ABCL TTM D&A is now at all-time high.
Performance
ABCL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ABCL Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.7% | +0.7% | +50.4% |
| 3 y3 years | +486.1% | +810.5% | +514.9% |
| 5 y5 years | +3265.4% | - | - |
ABCL Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.7% | +79.1% | at high | +687.5% | at high | +434.5% |
| 5 y | 5-year | -6.7% | +1572.7% | at high | +5828.0% | at high | >+9999.0% |
| alltime | all time | -6.7% | +3265.4% | at high | +5828.0% | at high | >+9999.0% |
AbCellera Biologics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $38.30 M(+0.7%) | $92.21 M(+50.4%) |
| Jun 2024 | - | $38.04 M(+462.2%) | $61.32 M(+100.8%) |
| Mar 2024 | - | $6.77 M(-25.7%) | $30.54 M(-1.1%) |
| Dec 2023 | $30.89 M(-6.7%) | $9.11 M(+22.9%) | $30.89 M(-16.8%) |
| Sep 2023 | - | $7.41 M(+2.1%) | $37.15 M(+1.9%) |
| Jun 2023 | - | $7.26 M(+1.9%) | $36.46 M(+3.4%) |
| Mar 2023 | - | $7.12 M(-53.6%) | $35.25 M(+6.5%) |
| Dec 2022 | $33.10 M | $15.36 M(+128.3%) | $33.10 M(+46.4%) |
| Sep 2022 | - | $6.73 M(+11.4%) | $22.61 M(+12.6%) |
| Jun 2022 | - | $6.04 M(+21.5%) | $20.08 M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $4.97 M(+2.3%) | $18.26 M(+5.8%) |
| Dec 2021 | $17.25 M(+227.3%) | $4.86 M(+15.6%) | $17.25 M(+15.0%) |
| Sep 2021 | - | $4.21 M(-0.2%) | $14.99 M(+27.9%) |
| Jun 2021 | - | $4.21 M(+6.3%) | $11.73 M(+36.5%) |
| Mar 2021 | - | $3.97 M(+52.1%) | $8.59 M(+63.0%) |
| Dec 2020 | $5.27 M(+185.4%) | $2.61 M(+178.3%) | $5.27 M(+97.9%) |
| Sep 2020 | - | $937.00 K(-13.2%) | $2.66 M(+54.3%) |
| Jun 2020 | - | $1.08 M(+67.2%) | $1.73 M(+167.2%) |
| Mar 2020 | - | $646.00 K | $646.00 K |
| Dec 2019 | $1.85 M(+101.2%) | - | - |
| Dec 2018 | $918.00 K | - | - |
FAQ
- What is AbCellera Biologics annual depreciation & amortization?
- What is the all time high annual D&A for AbCellera Biologics?
- What is AbCellera Biologics annual D&A year-on-year change?
- What is AbCellera Biologics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for AbCellera Biologics?
- What is AbCellera Biologics quarterly D&A year-on-year change?
- What is AbCellera Biologics TTM depreciation & amortization?
- What is the all time high TTM D&A for AbCellera Biologics?
- What is AbCellera Biologics TTM D&A year-on-year change?
What is AbCellera Biologics annual depreciation & amortization?
The current annual D&A of ABCL is $30.89 M
What is the all time high annual D&A for AbCellera Biologics?
AbCellera Biologics all-time high annual depreciation & amortization is $33.10 M
What is AbCellera Biologics annual D&A year-on-year change?
Over the past year, ABCL annual depreciation & amortization has changed by -$2.21 M (-6.67%)
What is AbCellera Biologics quarterly depreciation & amortization?
The current quarterly D&A of ABCL is $38.30 M
What is the all time high quarterly D&A for AbCellera Biologics?
AbCellera Biologics all-time high quarterly depreciation & amortization is $38.30 M
What is AbCellera Biologics quarterly D&A year-on-year change?
Over the past year, ABCL quarterly depreciation & amortization has changed by +$258.00 K (+0.68%)
What is AbCellera Biologics TTM depreciation & amortization?
The current TTM D&A of ABCL is $92.21 M
What is the all time high TTM D&A for AbCellera Biologics?
AbCellera Biologics all-time high TTM depreciation & amortization is $92.21 M
What is AbCellera Biologics TTM D&A year-on-year change?
Over the past year, ABCL TTM depreciation & amortization has changed by +$30.89 M (+50.37%)